Overcoming Barriers in Hospital-Based Health Technology Assessment (HB-HTA): International Expert Panel Consensus

Author:

Lipska Iga123ORCID,Di Bidino Rossella45ORCID,Niewada Maciej6,Nemeth Bertalan7,Bochenek Tomasz8,Kukla Monika3,Więckowska Barbara9,Sobczak Alicja1,Iłowiecka Katarzyna1ORCID,Zemplenyi Antal710,Martelli Nicolas1112ORCID,Martin Tess1112ORCID,Filiniuk Olena13,Kosyachenko Kostyantyn14,Sucu Rabia3,Piniazhko Oresta1516ORCID,Zaliska Olha16,Avdeyev Andrey17ORCID,Shanazarov Nasrulla17ORCID,von Pinoci Marina18,Hren Rok71920

Affiliation:

1. Health Policy Institute, 00-819 Warsaw, Poland

2. Medical Department, Academy of Applied Medical and Social Sciences, 82-300 Elbląg, Poland

3. Hospital-Based Health Technology Assessment Interest Group, Health Technology Assessment International, Edmonton, AB T6H 5P9, Canada

4. Fondazione Policlinico Universitario Agostino Gemelli IRCCS, 00168 Rome, Italy

5. Health Graduate School of Health Economics and Management (ALTEMS), Università Cattolica Del Sacro Cuore, 00168 Rome, Italy

6. Department of Experimental and Clinical Pharmacology, Medical University of Warsaw, 02-091 Warsaw, Poland

7. Syreon Research Institute, 1142 Budapest, Hungary

8. Department of Nutrition and Drug Research, Institute of Public Health, Faculty of Health Sciences, Jagiellonian University Medical College, 31-126 Krakow, Poland

9. Social Insurance Department, Warsaw School of Economics, 02-554 Warsaw, Poland

10. Center for Health Technology Assessment and Pharmacoeconomics Research, Faculty of Pharmacy, University of Pécs, 7624 Pécs, Hungary

11. Pharmacy Department, Georges Pompidou European Hospital, 75015 Paris, France

12. Faculty of Pharmacy, Université Paris-Saclay, GRADES, 91190 Orsay, France

13. Safe, Affordable, and Effective Medicines for Ukrainians (SAFEMed) Activity, Management Sciences for Health, 02000 Kyiv, Ukraine

14. Department of Management and Economy of Pharmacy, Bogomolets National Medical University, 01601 Kyiv, Ukraine

15. Department of Health Technology Assessment, State Expert Center, Ministry of Health of Ukraine, 01021 Kyiv, Ukraine

16. Department of Management and Economy of Pharmacy, Medicine Technology and Pharmacoeconomics, Faculty of Postgraduate Education, Danylo Halytsky Lviv National Medical University, 79010 Lviv, Ukraine

17. Medical Center Hospital of the President’s Affairs Administration of the Republic of Kazakhstan, Astana 010000, Kazakhstan

18. Care Quality Division, Hôpitaux Universitaires de Genève, 1211 Geneva, Switzerland

19. Institute of Mathematics, Physics, and Mechanics, 1000 Ljubljana, Slovenia

20. Faculty of Mathematics and Physics, University of Ljubljana, 1000 Ljubljana, Slovenia

Abstract

The purpose of this article is to investigate the common facilitators and barriers associated with the implementation of hospital-based health technology assessment (HB-HTA) across diverse hospital settings in seven countries. Through a two-round Delphi study, insights were gathered from a panel of 15 HTA specialists from France, Hungary, Italy, Kazakhstan, Poland, Switzerland, and Ukraine. Experts initially conducted a comprehensive review of the HB-HTA implementation in their respective countries, identifying the barriers and facilitators through descriptive analysis. Subsequently, panel experts ranked these identified barriers and facilitators on a seven-point Likert scale. A median agreement score ≥ 6 and interquartile range (IQR) ≤ 1 was accepted as reaching a consensus. Out of the 12 statements categorized as external and internal barriers and facilitators, the expert panel reached consensus on six statements (two barriers and four facilitators). The external barrier, which achieved consensus, was the lack of the formal recognition of the role of HB-HTA in national or regional legislations. The internal barrier reaching consensus was the limited availability of human resources dedicated to HB-HTA. This qualitative study indicates that HB-HTA still has progress to make before being formally accepted and integrated across most countries, although by building on the facilitating factors we identified there may be an opportunity for the implementation of internationally developed strategies to strengthen HB-HTA practices.

Funder

Slovenian Research and Innovation Agency

Publisher

MDPI AG

Reference55 articles.

1. Health Technology Assessment: The Pharmaceutical Industry Perspective;Schubert;Int. J. Technol. Assess. Health Care,2002

2. Using health technology assessment to assess the value of new medicines: Results of a systematic review and expert consultation across eight European countries;Angelis;Eur. J. Health Econ.,2018

3. The role of health technology assessment on pharmaceutical reimbursement in selected middle-income countries;Oortwijn;Health Policy,2010

4. Bertram, M., Dhaene, G., and Tan-Torres Edejer, T. (2021). Institutionalizing Health Technology Assessment Mechanisms: A How to Guide.

5. Health technology assessment of medical devices: What is different? An overview of three European projects;Mayer;Z. Evidenz Fortbild. Qual. Gesundheitswesen,2015

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3